NVR BCR Pill - red capsule/oblong, 22mm
Generic Name: nilotinib
Pill with imprint NVR BCR is Red, Capsule/Oblong and has been identified as Tasigna 150 mg. It is supplied by Novartis Pharmaceuticals.
Tasigna is used in the treatment of Chronic Myelogenous Leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Tasigna 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for NVR BCR
Tasigna
- Generic Name
- nilotinib
- Imprint
- NVR BCR
- Strength
- 150 mg
- Color
- Red
- Size
- 22.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals
- National Drug Code (NDC)
- 00078-0592
- Inactive Ingredients
-
silicon dioxide,
crospovidone,
lactose monohydrate,
magnesium stearate,
poloxamer 188,
gelatin,
ferric oxide red,
ferric oxide yellow,
titanium dioxide
Note: Inactive ingredients may vary.
More about Tasigna (nilotinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (30)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
